The latest news on MS treatments, research and specialist services.
MS Trust news
News from the MS Trust
Views and comment
MS Trust staff, MS health professionals and people with MS offer their perspectives on hot topics in the world of MS
Our free, quarterly newsletter for people with multiple sclerosis, their family and friends and supporters of the MS Trust.
Read our latest news
- Plan to extend personal health budgets
- Ocrevus (ocrelizumab) a year on
- Differences in cognition for people with SPMS
Understanding MS is hard enough as an adult, but for the increasing numbers of young people affected by MS, it can be huge challenge. This MS Awareness Week (23-29th April), the MS Trust is highlighting the impact MS can have on young people.
- Lemtrada and possible new side effects
- Tysabri study in SPMS
- Fighting for housing rights
- Risk of infections when on DMDs
MS awareness week is coming and we’re excited to announce that we’ll be launching MSTV, our new YouTube channel designed to help young people affected by MS.
Our day job is an important part of our identity, and being diagnosed with MS shouldn't mean giving up the things that make us who we are. But the unpredictability of MS may mean that you have to make some adjustments to how you approach work. In this guest blog, Carla, who was diagnosed with MS in 2008, suggests some simple changes you could make to help manage work life and MS.
Radio 1 DJ Scott Mills, whose mum has MS, offers his advice for young people navigating the ups and downs of growing up when you have a parent with MS.
- NICE says no to ocrelizumab for RRMS
- Childbirth pain relief doesn't increase relapse risk
- Cognitive training helps memory
- Prescription charge increase
- Flying with a disability
A public consultation on guidance on the use of disease modifying drugs (DMDs) for people in England with relapsing MS is open until 5 May 2018
Teresa and Des have set themselves a mammoth challenge of running 1000 miles in 2018 to support people living with MS.
- Scottish MPs told of neurology recruitment crisis
- MS nurses criticise cumbersome disability benefits system
- Fears that funding for independent living may be under threat
Zoe tells us why she and her partner Rob ran The Big Half for the MS Trust to help support people affected by MS.
- Stem cell study for people with highly active relapsing MS shows promising results
- Caroline Wyatt talks about stem cell treatment
- Siponimod secondary progressive MS results published in Lancet
Results from a large clinical trial of siponimod for secondary progressive MS (SPMS) have been published. Those taking siponimod had a 21% reduced risk of progression.
Sarah has signed up to take part in Miles for MS, our new distance challenge fundraising event. She tells us why she'll be walking 100 miles in May.
When Yvonne adopted her dog Bonnie, she could never have imagined the positive difference she’d make to her life. Last year Yvonne trained Bonnie up to become an Assistance Dog, and the benefits have been endless, as she explains in this guest blog.
Preliminary data from an international stem cell study for people with relapsing multiple sclerosis has reported that those having stem cell treatment had fewer relapses and improved disability levels.
- Calnexin increases number of immune cells crossing blood-brain barrier
- My wife has MS and is no longer interested in any sexual contact
A few years after her diagnosis of multiple sclerosis, Elaine had to come to terms with using a wheelchair. In this inspirational guest blog she discusses her own journey of acceptance, the reaction of others, and the positive and negative sides of life in a wheelchair.
- Zinbryta withdrawn due to safety fears
- Sunshine exposure reduces MS risk
- Paralympian with MS
- Unsuccessful trial of PPMS drug
The manufacturers of Zinbryta (daclizumab) announce worldwide withdrawal of Zinbryta following new reports of serious side effects